Medical Equipment

Nuclear Medicine Diagnostics Market Insights: Revenue Expected to Surpass $12.38 Billion by 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the nuclear medicine diagnostics market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Expected Growth Outlook For The Nuclear Medicine Diagnostics Market?

The nuclear medicine diagnostics market has experienced rapid expansion in recent years. It is projected to increase from $7.16 billion in 2024 to $7.88 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.2%. This historical growth can be attributed to advancements in medical imaging, the rising prevalence of chronic diseases, trends in an aging population, various clinical applications in oncology, and improved diagnostic accuracy and precision.

The nuclear medicine diagnostics market size is projected to experience substantial expansion in the coming years. This market is anticipated to reach $12.38 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.9%. This projected growth during the forecast period is fueled by factors such as the broadening use in neurology, its integration with other imaging techniques, advancements in precision medicine, the increasing need for theranostics, and worldwide initiatives for disease eradication. Key trends foreseen in this period encompass a move towards smaller, localized radiopharmacies, the specific application of nuclear medicine in neurological contexts, the development of radiomics and quantitative imaging analysis, partnerships for research and development, and a strong focus on radiation safety and dosimetry.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9415&type=smp

Which Growth Drivers Are Propelling The Nuclear Medicine Diagnostics Market?

The rising demand for nuclear medicine diagnostics is anticipated to propel the growth of the nuclear medicine diagnostics market in the future. Nuclear medicine involves using radioactive substances within the body to diagnose various illnesses or to precisely target and remove diseased or damaged organs and tissue for therapeutic purposes. The primary diagnostic applications of nuclear medicine are found in radiation and other crucial treatments. This increasing demand for nuclear medicine diagnostics stems from advantages such as delivering accurate results and facilitating better treatment decision-making. For instance, in April 2022, as per a report on nuclear medicine diagnostics published by the World Nuclear Association, a UK-based international organization promoting nuclear power, the annual volume of nuclear medicine treatments surpasses 40 million, and the requirement for radioisotopes is escalating at a rate of up to 5% every year. Additionally, 90% of medical procedures utilizing radioisotopes are carried out in more than 10,000 hospitals worldwide. Hence, the increasing demand for nuclear medicine diagnostics is expected to fuel the expansion of the nuclear medicine diagnostics market.

Which Segmentation Factors Are Most Significant In The Nuclear Medicine Diagnostics Market Analysis?

The nuclear medicine diagnosticsmarket covered in this report is segmented –

1) By Type: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

2) By Application: Cardiology, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Diagnostic Centers, Research Institutes

Subsegments:

1) By SPECT Radiopharmaceuticals: Technetium-99m-Based Radiopharmaceuticals, Iodine-123-Based Radiopharmaceuticals, Thallium-201-Based Radiopharmaceuticals, Other SPECT Radiopharmaceuticals

2) By PET Radiopharmaceuticals: Fluorine-18-Based Radiopharmaceuticals, Carbon-11-Based Radiopharmaceuticals, Gallium-68-Based Radiopharmaceuticals, Other PET Radiopharmaceuticals

What New Opportunities Are Emerging From Trends In The Nuclear Medicine Diagnostics Market?

Key companies operating in the nuclear medicine diagnostics market are concentrating on introducing advanced solutions, such as advanced medical technologies, to gain a competitive advantage. These advanced medical technologies are cutting-edge innovations in the medical field intended to improve patient outcomes, elevate the standard of care, and promote better health. For example, in August 2023, Gleneagles Hospital, a Malaysia-based company that provides medical and healthcare services, launched its Nuclear Medicine Unit. This nuclear medicine unit is a specialized facility within a hospital or medical center equipped with the most recent technology and staffed by highly skilled professionals. This facility is designed to offer early detection, diagnosis, and treatment of diseases by utilizing nuclear medicine imaging techniques.

Who Are The Most Influential Companies In The Nuclear Medicine Diagnostics Market?

Major companies operating in the nuclear medicine diagnostics market include Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., Mallinckrodt Pharmaceuticals, Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, Curium SAS, Cardinal Health Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, Telix Pharmaceuticals Limited, Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC, Navidea Biopharmaceuticals Inc., Cyclopharm Limited, Isologic Innovative Radiopharmaceuticals, Clarity Pharmaceuticals Limited, Actinium Pharmaceuticals Inc., Jubilant DraxImage Inc., PharmaLogic Holdings Corp, Institute of Isotopes Co Ltd., Global Medical Solutions LLC, Theragnostics Ltd., Eczacıbaşı-Monrol Nuclear Products Co.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

Which Region Holds The Largest Share In The Nuclear Medicine Diagnostics Market Today?

North America was the largest region in the nuclear medicine diagnostics market in 2024. The regions covered in the nuclear medicine diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9415&type=smp

Browse Through More Reports Similar to the Global Nuclear Medicine Diagnostics Market 2025, By The Business Research Company

Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

Point Of Care Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795